Family history of cancer and utilization of prostate, colorectal and skin cancer screening tests in U.S. men

Preventive Medicine

Volumn 44, Issue 5, 2007, Pages 459-464

  Shah, Mona ^a   Zhu, Kangmin ^a   Palmer, Richard C ^b   Wu, Hongyu ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

Author keywords

Colorectal carcinoma; Family history; Prostate neoplasm; Screening; Skin cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER SCREENING; COLORECTAL CANCER; CONTROLLED STUDY; DEMOGRAPHY; FAMILY HISTORY; HEALTH SURVEY; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SCREENING TEST; SKIN CANCER; UNITED STATES;

ADULT; AGED; COLORECTAL NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; SKIN NEOPLASMS; UNITED STATES;

EID: 34247844405     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ypmed.2006.12.016     Document Type: Article

References (45)

1. Aitken J.F., Youl P.H., Janda M., Elwood M., Ring I.T., Lowe J.B., and Firman D.W. Validity of self-reported skin screening histories. Am. J. Epidemiol. 159 (2004) 1098-1105
2. American Cancer Society. Cancer Facts and Figures 2006 (2006), American Cancer Society, Atlanta, GA
3. American Medical Association. Cancer screening guidelines [perform a search for specific types of cancer]. viewed 10 July, 2006 .
4. Baier M., Calonge N., Cutter G., et al. Validity of self-reported colorectal cancer screening behavior. Cancer Epidemiol. Biomarkers Prev. 9 (2000) 229-232
5. Catalona W.J., Antenor J.A., Roehl K.A., and Moul J.W. Screening for prostate cancer in high risk populations. J. Urol. 168 5 (2002) 1980-1983
6. Codori A.M., Petersen G.M., Miglioretti D.L., and Boyd P. Health beliefs and endoscopic screening for colorectal cancer, potential for cancer prevention. Prev. Med. 33 2 Pt. 1 (2001) 128-136
7. Costanza M.E., Luckmann R., Stoddard A.M., Avrunin J.S., White M.J., Stark J.R., Clemow L., and Rosal M.C. Applying a stage model of behavior change to colon cancer screening. Prev. Med. 41 3-4 (2005) 707-719
8. Curry S.J., and Emmons K.M. Theoretical models for predicting and improving compliance with breast cancer screening. Ann. Behav. Med. 16 4 (1994) 302-316
9. Etzi S., Lane D.S., and Grimson R. The use of mammography vans by low-income women: the accuracy of self-reports. Am. J. Public Health 84 1 (1994) 107-109
10. Fontaine K.R., Heo M., and Allison D.B. Body weight and cancer screening among women. J. Women's Health Gend.-Based Med. 10 5 (2001) 463-470
11. Fountain J.W., Bale S.J., Housman D.E., and Dracopoli N.C. Genetics of melanoma. Cancer Surv. 9 (1990) 645-671
12. Fuchs C.S., Giovannucci E.L., Colditz G.A., Hunter D.J., Speizer F.E., and Willett W.C. A prospective study of family history and the risk of colorectal cancer. N. Engl. J. Med. 331 (1994) 1669-1674
13. Gilbert, A., Kanarek, N., 2005. Colorectal cancer screening, physician recommendation is influential advice to Marylanders. Aug; Prev. Med. 41 (2), 367-79.
14. Greene M.H., and Fraumeni Jr. J.F. The hereditary variant of malignant melanoma. In: Clark W., Goldman L., and Mastrangelo M. (Eds). Human Malignant Melanoma (1979), Grune, New York 139-166
15. Herbert C., Launoy G., and Gignoux M. Factors affecting compliance with colorectal cancer screening in France, differences between intention to participate and actual participation. Eur. J. Cancer Prev. 6 1 (1997) 44-52
16. Jacobsen P.B., Lamonde L.A., Honour M., Kash K., Hudson P.B., and Pow-Sang J. Relation of family history of prostate cancer to perceived vulnerability and screening behavior. Psychooncology 13 2 (2004) 80-85
17. Jordan T.R., Price J.H., King K.A., Masyk T., and Bedell A.W. The validity of male patients' self-reports regarding prostate cancer screening. Prev. Med. 28 3 (1999) 297-303
18. Law M.R., Morris J.K., and Wald N.J. The importance of age in screening for cancer. J. Med. Screen. 6 1 (1999) 16-20
19. Lipkus I.M., Iden D., Terrenoire J., and Feaganes J.R. Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer. Cancer Epidemiol. Biomarkers Prev. 8 6 (1999) 533-539
20. Montaño D.E., and Taplin S.H. A test of an expanded theory of reasoned action to predict mammography participation. Soc. Sci. Med. 32 6 (1991) 733-741
21. Myers R.E., Balshem A.M., Wolf T.A., Ross E.A., and Millner L. Adherence to continuous screening for colorectal neoplasia. Med. Care 31 6 (1993) 508-519
22. Myers R.E., Ross E., Jepson C., Wolf T., Balshem A., Millner L., et al. Modeling adherence to colorectal cancer screening. Prev. Med. 23 2 (1994) 142-151
23. Myers R.E., Wolf T.A., McKee L., McGrory G., Burgh D.Y., Nelson G., and Nelson G.A. Factors associated with intention to undergo annual prostate cancer screening among African American men in Philadelphia. Cancer 78 3 (1996) 471-479
24. Myers R.E., Vernon S.W., Tilley B.C., Lu M., and Watts B.G. Intention to screen for colorectal cancer among white male employees. Prev. Med. 27 2 (1998) 279-287
25. National Center for Health Statistics, 2002. 2000 National Health Interview Survey (NHIS) Public Use Data Release, NHIS Survey Description. Vol. 2001. Hyattsville, MD. Available at, ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NHIS/2000/s rvydesc.pdf. [Accessed September 5, 2005].
26. Paquette E.L., Sun L., Paquette L.R., Connelly R., Mcleod D.G., and Moul J.W. Improved prostate cancer-specific survival and other disease parameters: impact of prostate-specific antigen testing. Urology 60 5 (2002) 756-759
27. Pignone M.P., Bucoltz D., and Harris R. Patient interest and preferences for colon cancer screening. J. Gen. Intern. Med. 14 7 (1999) 432-437
28. Pignone M., Rich M., Teutsch S.M., Berg A.O., and Lohr K.N. Screening for colorectal cancer in adults at average risk. Summary of the evidence for the US Preventive Services Task Force. Ann. Intern. Med. 137 (2002) 132-141
29. Rager E.L., Bridgeford E.P., and Ollila D.W. Cutaneous melanoma, update on prevention, screening, diagnosis, and treatment. Am. Fam. Phys. 72 2 (2005) 269-276
30. Rich J.S., and Black W.C. When should we stop screening?. Eff. Clin. Pract. 3 2 (2000) 78-84
31. Robie P.W. Cancer screening in the elderly. J. Am. Geriatr. Soc. 37 9 (1989) 888-893
32. SAS Software [computer program], 2001. Version 8.02. SAS Institute Inc., Cary, NC.
33. Schoenfeld P.S., Fincher R.K., and Military Colorectal Cancer Screening Trials Group. Colonoscopic surveillance of patients with a family history of colon cancer and a history of normal colonoscopy, is a five-year interval between colonoscopies appropriate?. Clin. Gastroenterol. Hepatol. 1 4 (2003) 310-314
34. Smalley W. Fecal occult blood testing done in setting of an office-based digital rectal exam is not useful. Evid. -Based Gastroenterol. 6 2 (2005) 44-45
35. Smith R.A., Cokkinides V., and Eyre H.J. American Cancer Society guidelines for the early detection of cancer, 2006. CA Cancer J. Clin. 56 (2006) 11-25
36. Steinberg G.D., Carter B.S., Beaty T.H., Childs B., and Walsh P.C. Family history and the risk of prostate cancer. Prostate 17 (1990) 337-347
37. Tucker M.A., Fraser M.C., Goldstein A.M., Elder D.E., Guerry D., and Organic S.M. Risk of melanoma and other cancers in melanoma-prone families. J. Invest. Dermatol. 100 (1993) 350-355
38. United States Preventive Services Task Force 2005, Guide to Clinical Preventive Services. viewed 10 July, 2006. .
39. Vernon S.W. Participation in colorectal cancer screening, a review. J. Natl. Cancer Inst. 89 19 (1997) 1406-1422
40. Volk R.J., and Cass A.R. The accuracy of primary care patients' self-reports of prostate-specific antigen testing. Am. J. Prev. Med. 22 1 (2002) 56-58
41. Weinrich S.P., Weinrich M.C., Boyd M.D., and Atkinson C. The impact of prostate cancer knowledge on cancer screening. Oncol. Nurs. Forum. 25 3 (1998) 527-534
42. Weller D., Pinnock C., Silagy C., Hiller J.E., and Marshall V.R. Prostate cancer testing in SA men, influence of sociodemographic factors, health beliefs and LUTS. Aust. N. Z. J. Public Health 22 3 (1998) 400-402
43. Winawer S., Fletcher R., Rex D., Bond J., Burt R., Ferrucci J., et al. Colorectal cancer screening and surveillance, clinical guidelines and rationale-Update based on new evidence. Gastroenterology 1242 (2003) 544-560
44. Wolf A.M., and Schorling J.B. Does informed consent alter elderly patients' preferences for colorectal cancer screening? Results of a randomized trial. J. Gen. Intern. Med. 15 1 (2000) 24-30
45. Zoorob R., Anderson R., Cefalu C., and Sidani M. Cancer screening guidelines. Am. Fam. Physician. 63 (2001) 1101-1112